The chemical class labeled as NRDE-2 Inhibitors encompasses a range of compounds that indirectly influence the activity of NRDE-2, a protein integral to the RNA interference (RNAi) pathway. These inhibitors do not directly target NRDE-2. Instead, they act on various cellular processes and pathways that are upstream or parallel to NRDE-2 function, thereby modulating its activity. The primary mechanism of action for these inhibitors involves alterations in gene expression regulation, achieved through the modulation of DNA methylation, histone modification, and key cellular signaling pathways. By influencing these fundamental biological processes, the inhibitors can affect the expression levels and functionality of NRDE-2, thereby indirectly impacting RNAi mechanisms.
The inhibitors in this class typically function by targeting enzymes responsible for DNA methylation and histone modifications, such as DNA methyltransferases and histone deacetylases. By inhibiting these enzymes, the compounds can alter the chromatin structure, leading to changes in the transcriptional activity of genes, including those related to the RNAi pathway and NRDE-2. This alteration in gene expression is a crucial aspect of the inhibitors' mechanism of action. Additionally, some compounds in this class target key signaling pathways, such as the PI3K/Akt pathway and the mTOR pathway, which are involved in various cellular processes, including protein synthesis and gene expression. By modulating these signaling pathways, the inhibitors can indirectly influence the synthesis and function of NRDE-2. The overall impact of these inhibitors is a change in the cellular environment and gene expression profile, which can affect the expression or activity of NRDE-2 and consequently, the RNAi pathway. The inhibitors in the NRDE-2 Inhibitors class represent a sophisticated approach to modulating gene expression and RNAi mechanisms. Their ability to influence key regulatory processes in the cell provides a means to study the complex interactions and functions within the RNAi pathway. By targeting the upstream regulatory mechanisms and signaling pathways that govern gene expression and protein synthesis, these inhibitors offer a strategic method to indirectly modulate the activity of NRDE-2, providing valuable insights into the role and regulation of RNAi in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound inhibits DNA methyltransferases, leading to reduced DNA methylation and altered gene expression, which can include the downregulation of NRDE-2. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG108 inhibits DNA methyltransferases, affecting DNA methylation and potentially decreasing the expression of NRDE-2 by altering transcriptional regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, causing increased histone acetylation and potentially altering the expression of genes involved in RNAi, including NRDE-2. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat, a histone deacetylase inhibitor, enhances histone acetylation and can modulate gene expression profiles, potentially affecting NRDE-2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, affecting multiple signaling pathways. This disruption can lead to altered expression or activity of RNAi-related proteins, including NRDE-2. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A inhibits Sp1 transcription factor, potentially decreasing the transcription of genes like NRDE-2 that are involved in RNAi pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate, as a histone deacetylase inhibitor, alters chromatin structure and can influence the expression of NRDE-2 by modifying gene accessibility. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine inhibits DNA methyltransferases, leading to hypomethylation and potentially reduced expression of NRDE-2 by altering gene transcription. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Entinostat inhibits histone deacetylases, leading to changes in chromatin structure and potentially influencing NRDE-2 expression by altering gene transcription patterns. | ||||||